PANCRAGEN 20 MG - kit by
Peptide Hubs

PANCRAGEN 20 MG

CLASSIFICATION: ORGAN-SPECIFIC PEPTIDE
ACTIVE SUBSTANCE: PANCRAGEN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: APPROX. 6–8 HOURS
DOSAGE: 20–40 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

Out of stock

PANCRAGEN 20 MG Detailed

Pancragen 20 mg – Peptide Hubs

Pancragen is an organ-specific peptide complex designed to support pancreatic health, insulin signaling, and beta-cell activity. Derived from natural cytomedin peptides targeting the pancreas, Pancragen may regulate gene expression, enhance tissue repair, and support glucose metabolism in research settings. Peptide Hubs provides Pancragen in a 20 mg lyophilized format suitable for advanced metabolic and endocrine research.

Mechanism of Action

Pancragen's mechanism focuses on restoring pancreatic tissue function at the molecular level. The short peptides in Pancragen bind to nuclear structures and modulate gene expression, potentially enhancing insulin production and protecting beta cells. This mechanism aligns with cytogenetic peptide research as discussed in this NIH article on peptide bioregulators.

Primary Research Applications

  • Pancreatic regeneration and beta-cell support studies
  • Insulin pathway modulation research
  • Preclinical models of diabetes and metabolic syndrome
  • Endocrine and glucose regulation studies

Pancragen is frequently combined with Semaglutide or MOTS-c in research focused on metabolic and glycemic regulation. For oxidative stress and mitochondrial protection, Humanin is a common stack. DNA integrity and cellular repair models may also include FOX04-DRI or L-Glutathione.

Suggested Experimental Use

  • Dosage: 20–40 mg per week (e.g. 10 mg 2–4x/week)
  • Administration: Subcutaneous injection in preclinical settings
  • Duration: Typically 4–6 weeks in pancreas-focused protocols

Stacking Recommendations

  • Semaglutide – GLP-1 pathway synergy
  • Humanin – mitochondrial and beta-cell protection
  • MOTS-c – metabolic resilience and energy balance
  • L-Glutathione – antioxidant and DNA support

Legal Disclaimer

Pancragen is not approved by the FDA and is intended for research purposes only. No androgenic, estrogenic, or hepatotoxic effects have been reported in preclinical data. Proper storage and handling protocols should be followed as per institutional guidelines.

Frequently Asked Questions

What is Pancragen used for in research?

Pancragen is studied for its role in pancreatic tissue repair, insulin signaling, and beta-cell function support in models of metabolic dysfunction.

Does Pancragen affect insulin production?

Research suggests Pancragen may help support insulin gene expression and pancreatic beta-cell recovery, though it is not a replacement for insulin itself.

Can Pancragen be stacked with GLP-1 agonists?

Yes. It is often stacked with compounds like Semaglutide or MOTS-c in studies related to glucose homeostasis and insulin sensitivity.

Is Pancragen FDA approved?

No. Pancragen is not FDA-approved. It is intended for laboratory use only and is not sold for human or veterinary administration.

No reviews found

Please log in to write PANCRAGEN 20 MG review.

Related Offers
Lab Tested
US Domestic & International
IPAMORELIN 5 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

40.00 USD  
Lab Tested
US Domestic & International
TB 500 5 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

30.00 USD  
Lab Tested
US Domestic & International
TB 500/BPC 157 10 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

40.00 USD  
Lab Tested
US Domestic & International
BPC 157 5 MG - 2 ml by Peptide Hubs
Peptide Hubs

CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

20.00 USD  
Lab Tested
US Domestic & International
MELANOTAN 2 10 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

40.00 USD  
TESAMORELIN 5 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

Out of stock
SERMORELIN 5 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

Out of stock
SEMAX 30 MG - vial by Peptide Hubs
Peptide Hubs

CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

Out of stock

Add in Cart - Product(s)

Close Button
Empty

Total Cost: